Charles River Laboratories International, Inc. (CRL)
298.11
-0.47
(-0.16%)
USD |
NYSE |
Aug 25, 12:54
Charles River Laboratories International EPS Diluted (Quarterly) : -0.0309 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0309 |
| March 31, 2026 | -0.3032 |
| December 31, 2025 | -5.619 |
| September 30, 2025 | 1.101 |
| June 30, 2025 | 1.061 |
| March 31, 2025 | 0.5008 |
| December 31, 2024 | -4.218 |
| September 30, 2024 | 1.331 |
| June 30, 2024 | 1.736 |
| March 31, 2024 | 1.407 |
| December 31, 2023 | 3.624 |
| September 30, 2023 | 1.693 |
| June 30, 2023 | 1.885 |
| March 31, 2023 | 2.005 |
| December 31, 2022 | 3.648 |
| September 30, 2022 | 1.881 |
| June 30, 2022 | 2.132 |
| March 31, 2022 | 1.812 |
| December 31, 2021 | 2.669 |
| September 30, 2021 | 2.006 |
| June 30, 2021 | 1.723 |
| March 31, 2021 | 1.205 |
| December 31, 2020 | 2.806 |
| September 30, 2020 | 2.030 |
| June 30, 2020 | 1.342 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.016 |
| December 31, 2019 | 1.611 |
| September 30, 2019 | 1.465 |
| June 30, 2019 | 0.8805 |
| March 31, 2019 | 1.115 |
| December 31, 2018 | 1.212 |
| September 30, 2018 | 1.224 |
| June 30, 2018 | 1.095 |
| March 31, 2018 | 1.078 |
| December 31, 2017 | -0.6297 |
| September 30, 2017 | 1.084 |
| June 30, 2017 | 1.116 |
| March 31, 2017 | 0.97 |
| December 31, 2016 | 0.93 |
| September 30, 2016 | 0.79 |
| June 30, 2016 | 0.73 |
| March 31, 2016 | 0.78 |
| December 31, 2015 | 0.67 |
| September 30, 2015 | 0.79 |
| June 30, 2015 | 1.02 |
| March 31, 2015 | 0.66 |
| December 31, 2014 | 0.57 |
| September 30, 2014 | 0.68 |
| June 30, 2014 | 0.74 |
| March 31, 2014 | 0.67 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 1.530 |
| Medpace Holdings, Inc. | 4.250 |
| Fortrea Holdings, Inc. | -0.1392 |
| Avantor, Inc. | 0.0563 |
| Champions Oncology, Inc. | -0.048 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.76M |
| Revenue (Quarterly) | 1.004B |
| Total Expenses (Quarterly) | 1.006B |
| Enterprise Value | 17.12B |
| Gross Profit Margin (Quarterly) | 36.29% |
| Profit Margin (Quarterly) | -0.08% |
| Earnings Yield | -1.63% |
| Operating Earnings Yield | 3.71% |
| Normalized Earnings Yield | 0.6311 |